All posts by Simmons Hanly Conroy
By Simmons Hanly Conroy | August 28, 2017
No Asbestos Ban in Place Means Workers Will Keep Dying From Mesothelioma
The use of asbestos in building materials has decreased in the United States during the past several decades due to its worldwide recognition as a deadly carcinogen. At the same time, however,… Read More
By Simmons Hanly Conroy | August 25, 2017
Celebrating Meso Heroes From Coast to Coast
In 2011, Mike Mattmuller was only 29-years-old when an x-ray revealed he had mesothelioma – an often fatal form of cancer caused by asbestos exposure that typically afflicts people twice his age.… Read More
By Simmons Hanly Conroy | August 22, 2017
After $417M Loss, Johnson & Johnson Still Refuses to Acknowledge Suffering of Misinformed Talc Consumers
In the first talc trial to be held before a state jury in California, multinational pharma giant Johnson & Johnson lost $417 million in compensatory and punitive damages to a Los Angeles… Read More
By Simmons Hanly Conroy | August 21, 2017
Mesothelioma and Depression: Coping Strategies for Individuals and Their Families
Nearly 3,000 people are diagnosed with mesothelioma every year, all of whom face uncertain futures that may include chemotherapy, radiation and mounting hospital bills. While many tend to focus on treating the… Read More
By Simmons Hanly Conroy | August 15, 2017
ADAO: The Face of Asbestos Victims and their Fight to Ban Asbestos
Today begins our series of Miles for Meso spotlights. Every week between now and race day on Sept. 30, the Simmons Hanly Conroy blog will feature a survivor, warrior, volunteer or organization… Read More
By Simmons Hanly Conroy | August 10, 2017
Communities Band Together to Fight Opioid Epidemic in Nationwide Lawsuit
At a vital turning point in opioid litigation, law firms like Simmons Hanly Conroy are now casting their net beyond chronic pain patients, whose lawsuits against opioid makers have generated millions in… Read More
By Simmons Hanly Conroy | August 2, 2017
Makers of Blood Pressure Drug Benicar Settle 2,300 Lawsuits in a Federal N.J. Court
Daiichi Sankyo, Inc., a Tokyo-based drug maker worth an estimated $12.4 billion, agreed to settle nearly 2,300 patient lawsuits against its blood pressure medication Benicar® (olmesartan medoxomil) and its sister medications Benicar… Read More
By Simmons Hanly Conroy | August 2, 2017
Notorious Pedophilic Priest Set to Be Released From Prison
The upcoming release of Paul Shanley, defrocked priest and convicted child-rapist, is an appalling reminder of the injustice suffered by survivors of clergy abuse. After spending 12 years in prison, Shanley will… Read More
By Simmons Hanly Conroy | July 27, 2017
12 Ways to Celebrate, Commemorate & Support on World Lung Cancer Day
“Don’t smoke – you could get lung cancer.” You may have heard these words at some point in your life. It’s often one of the leading arguments to convince people to avoid… Read More
By Simmons Hanly Conroy | July 18, 2017
FDA Pulls Addictive Opioid Pain Med off the Market as Lawsuits Against Pill Manufacturers Pile Up
On July 8 – in a first of its kind decision – the Food and Drug Administration (FDA) requested a pharmaceutical company to pull off the market one of its opioid products… Read More